Modification of Daxx by small ubiquitin-related modifier-1

被引:75
作者
Jang, MS
Ryu, SW
Kim, E
机构
[1] PaiChai Univ, Res Ctr Biomed Resources, Seo Gu, Taejon 302735, South Korea
[2] PaiChai Univ, Div Life Sci, Seo Gu, Taejon 302735, South Korea
关键词
Daxx; SUMO-1; sumoylation; modification; POD;
D O I
10.1016/S0006-291X(02)00699-X
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Small ubiquitin-related modifier-1 (SUMO-1) is a protein that is covalently modified to various cellular proteins and protects cells against both anti-Fas and TNF-induced cell death. Previously, we reported that the C-terminus of Daxx interacted with Ubc9, an E2 type SUMO-I conjugating enzyme, as well as with SUMO-1. In BOSC23 cells expressing FLAG-Daxx together with HA-SUMO-1, 110 and 130 kDa Daxx appeared and the 130kDa band bound to both anti-HA and anti-FLAG antibodies. This means that Daxx can be covalently modified by SUMO-L Substitution of K630 and K631 abrogated the modification of Daxx by SUMO1, implying that K630 and K631 were essential for sumoylation. Daxx (K630, 631A) and Daxx (K634, 636, 637A) in which the putative C-terminal nuclear localization signals (NLSs) were disrupted appeared in the nucleus, suggesting that the C-terminal NLS was not functional. Daxx (K630, 631A), the sumoylation defective mutant, was able to interact with PML and co-localized with PML in the PML oncogenic domains (PODs). Thus, our data show that sumoylation status of Daxx does not affect its presence in PODs. (C) 2002 Elsevier Science (USA). All rights reserved.
引用
收藏
页码:495 / 500
页数:6
相关论文
共 43 条
[1]   Structure determination of the small ubiquitin-related modifier SUMO-1 [J].
Bayer, P ;
Arndt, A ;
Metzger, S ;
Mahajan, R ;
Melchior, F ;
Jaenicke, R ;
Becker, J .
JOURNAL OF MOLECULAR BIOLOGY, 1998, 280 (02) :275-286
[2]  
Boddy MN, 1996, ONCOGENE, V13, P971
[3]   Activation of apoptosis signal regulating kinase 1 (ASK1) by the adapter protein Daxx [J].
Chang, HY ;
Nishitoh, H ;
Yang, XL ;
Ichijo, H ;
Baltimore, D .
SCIENCE, 1998, 281 (5384) :1860-1863
[4]   SUMO-1 modification of IκBα inhibits NF-κB activation [J].
Desterro, JMP ;
Rodriguez, MS ;
Hay, RT .
MOLECULAR CELL, 1998, 2 (02) :233-239
[5]   A NOVEL MACROMOLECULAR STRUCTURE IS A TARGET OF THE PROMYELOCYTE-RETINOIC ACID RECEPTOR ONCOPROTEIN [J].
DYCK, JA ;
MAUL, GG ;
MILLER, WH ;
CHEN, JD ;
KAKIZUKA, A ;
EVANS, RM .
CELL, 1994, 76 (02) :333-343
[6]   Regulation of p53 activity in nuclear bodies by a specific PML isoform [J].
Fogal, V ;
Gostissa, M ;
Sandy, P ;
Zacchi, P ;
Sternsdorf, T ;
Jensen, K ;
Pandolfi, PP ;
Will, H ;
Schneider, C ;
Del Sal, G .
EMBO JOURNAL, 2000, 19 (22) :6185-6195
[7]   CHARACTERIZATION OF A ZINC FINGER GENE DISRUPTED BY THE T(15,17) IN ACUTE PROMYELOCYTIC LEUKEMIA [J].
GODDARD, AD ;
BORROW, J ;
FREEMONT, PS ;
SOLOMON, E .
SCIENCE, 1991, 254 (5036) :1371-1374
[8]   Communication - Preferential interaction of sentrin with a ubiquitin-conjugating enzyme, Ubc9 [J].
Gong, LM ;
Kamitani, T ;
Fujise, K ;
Caskey, LS ;
Yeh, ETH .
JOURNAL OF BIOLOGICAL CHEMISTRY, 1997, 272 (45) :28198-28201
[9]   Activation of p53 by conjugation to the ubiquitin-like protein SUMO-1 [J].
Gostissa, M ;
Hengstermann, A ;
Fogal, V ;
Sandy, P ;
Schwarz, SE ;
Scheffner, M ;
Del Sal, G .
EMBO JOURNAL, 1999, 18 (22) :6462-6471
[10]   P53 and PML: new partners in tumor suppression [J].
Gottifredi, V ;
Prives, C .
TRENDS IN CELL BIOLOGY, 2001, 11 (05) :184-187